brello health glp 1 : r/tirzepatidecompound Brello Review: GLP-1 Access &

doi: 10.1016/S0140-6736(16)30173-8

168 Indeed, liver biopsies confirm that the prevalence of clinically significant fibrosis in MASLD and MASH patients is only 20.27% and 35.14%, respectively, 169 with lower proportions in patients with normal or lean body weight, 170 suggesting that antifibrotic treatment may not be necessary for a larger proportion of patients

Xie C, Alkhouri N, Elfeki MA

How Orforglipron Differs From Rybelsus This is where confusion often happens

Gastroparesis can interfere with normal digestion, causing nausea, vomiting, and stomach pain

There is not enough research to confirm causation, he continued